Pediatric hypnotic prescribing in Japan increased over the past decade, with a significant acceleration after the April 2020 COVID-19 state of emergency.
The proportion of children and adolescents prescribed hypnotics in Japan rose from 0.4% in 2014 to 1.0% in 2023. Interrupted time-series analysis showed a significant post-emergency slope increase of 3.64 prescriptions per 100,000 population per month (95% CI, 2.69 to 4.58; P < 0.001), though pre-existing trends were already evident.
Evidence Score
Study Evidence
Study 1. Ten-year trends in pediatric hypnotic prescribing before and during the COVID-19 pandemic in Japan.
observationalMatsuyama N, Iwamoto K, Miyata S, Imai T, Ikeda M ยท Sleep medicine (2026)
Result:
Mechanism Graph
Limitations
- โ Observational study design cannot establish causality between pandemic and prescribing changes
- โ Sensitivity analyses showed that post-emergency increases were attenuated when excluding melatonin, suggesting results are partially driven by a specific drug class
Frequently Asked Questions
What was the overall increase in pediatric hypnotic prescribing in Japan from 2014 to 2023?โผ
The proportion increased from 0.4% (2800 of 673,141) in 2014 to 1.0% (23,977 of 2,401,028) in 2023.
Did the COVID-19 pandemic cause a sudden jump in hypnotic prescriptions for children?โผ
No, the immediate level change after April 2020 was not statistically significant, but the slope of increase significantly accelerated by 3.64 prescriptions per 100,000 per month.
Which demographic groups showed the largest increases?โผ
Larger increases were observed among adolescents and females.
What types of hypnotics changed in prescribing patterns?โผ
Benzodiazepines and benzodiazepine receptor agonists decreased, while melatonin receptor agonists and orexin receptor antagonists increased.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Matsuyama N, Iwamoto K, Miyata S, Imai T, Ikeda M. "Ten-year trends in pediatric hypnotic prescribing before and during the COVID-19 pandemic in Japan.." Sleep medicine, 2026. PMID: 42392020 DOI: 10.1016/j.sleep.2026.109108